Cytokeratin 6 Antibody / CK6 Antibody

Cytokeratin 6 Antibody Overview

Cytokeratin 6 Antibody reagents target keratin 6 (KRT6), a type II intermediate filament protein expressed in stratified epithelial tissues. KRT6 is strongly upregulated during wound healing, tissue repair, and hyperproliferative conditions such as psoriasis. It is co-expressed with keratins 16 and 17, forming part of the cytoskeletal network that maintains epithelial strength and resilience.

KRT6 is normally expressed in the outer root sheath of hair follicles, the nail bed, oral mucosa, and palms and soles. In disease states, elevated KRT6 expression is seen in squamous cell carcinomas and inflammatory skin disorders. The Cytokeratin 6 Antibody is therefore a critical reagent for studying skin biology, wound healing, and oncology. The CK6 Antibody also provides broader applications across dermatology, pathology, and translational medicine.

Why Choose Cytokeratin 6 Antibodies from NSJ Bioreagents?

NSJ Bioreagents supplies Cytokeratin 6 Antibodies validated for immunohistochemistry, western blotting, immunofluorescence, and ELISA. Each Cytokeratin 6 Antibody is thoroughly tested to ensure specificity, reproducibility, and minimal background staining.

By selecting Cytokeratin 6 Antibodies from NSJ Bioreagents, researchers gain reagents optimized for reliability and clarity. Our antibodies provide robust staining in skin and epithelial tissues, reproducible detection in protein lysates, and strong performance across experimental platforms. With detailed datasheets, positive controls, and validated protocols, NSJ Bioreagents ensures reproducible results in both discovery and clinical settings.

Applications of Cytokeratin 6 Antibodies

The Cytokeratin 6 Antibody supports diverse research areas ranging from skin biology to oncology.

1) Dermatology and Skin Biology

• Cytokeratin 6 Antibodies highlight expression in palms, soles, and mucosal epithelium.

• The Cytokeratin 6 Antibody tracks keratinocyte activation in psoriasis and hyperkeratotic lesions.

• CK6 Antibody reagents clarify structural roles in epidermal biology.

2) Wound Healing and Tissue Repair

• Cytokeratin 6 Antibodies detect keratin upregulation in regenerating epithelia.

• The Cytokeratin 6 Antibody monitors keratinocyte proliferation during wound closure.

• CK6 Antibody reagents support regenerative medicine studies on epithelial repair.

3) Oncology and Tumor Biology

• Cytokeratin 6 Antibodies identify squamous cell carcinomas and other epithelial tumors.

• The Cytokeratin 6 Antibody provides diagnostic support in pathology panels.

• CK6 Antibody reagents highlight tumor aggressiveness and invasive potential.

4) Developmental and Stem Cell Biology

• Cytokeratin 6 Antibodies track keratin expression during embryonic skin development.

• The Cytokeratin 6 Antibody validates lineage specification in epithelial stem cell models.

5) Inflammation and Immune Responses

• Cytokeratin 6 Antibodies clarify epithelial remodeling in chronic inflammation.

• The Cytokeratin 6 Antibody supports research into inflammatory skin disorders.

6) Translational and Clinical Research

• Cytokeratin 6 Antibodies support biomarker discovery in dermatology and oncology.

• The Cytokeratin 6 Antibody contributes to patient monitoring in clinical studies.

• CK6 Antibody reagents provide reproducibility in translational workflows.

Why Are Cytokeratin 6 Antibodies Important?

KRT6 plays key roles in epithelial resilience, wound healing, and disease. The Cytokeratin 6 Antibody equips researchers with precise tools for studying keratin expression in both normal and pathological conditions, while the CK6 Antibody extends these applications into diagnostics and translational medicine.

In skin biology, Cytokeratin 6 Antibodies highlight keratinocyte activation in hyperproliferative disorders. In oncology, the Cytokeratin 6 Antibody helps classify squamous cell carcinomas and related malignancies. In wound healing research, CK6 Antibody reagents track epithelial repair and regeneration.

Clinically, KRT6 expression serves as a marker for skin pathology and tumor classification. Accurate detection with Cytokeratin 6 Antibodies ensures reproducibility and diagnostic clarity, linking laboratory science to patient care.

Conclusion

Cytokeratin 6 is a key epithelial protein involved in structural stability, wound healing, and disease. The Cytokeratin 6 Antibody equips researchers and clinicians with validated reagents for studying KRT6 expression in skin biology, inflammation, and oncology, while the CK6 Antibody provides complementary tools for diagnostics and translational research. By ensuring specificity and reproducibility, these antibodies remain indispensable for advancing keratin biology and improving clinical outcomes.